PACB R&D Expense Growth
Pacific Biosciences Of California · R&D Expense Growth
PACB R&D Expense Growth
Latest reported-27.88%period ending
PACB FY R&D Growth (YoY) (0.00% → -27.88%)
Latest values, visible window
High-resolution chart · PNG
PACB r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -27.8791% | |
| -27.9147% | |
| -3.0207% | |
| 70.9493% | |
| 75.9867% | |
| 7.5834% | |
| -4.7353% | |
| -4.1792% | |
| -3.3912% | |
| 11.8746% | |
| 25.3162% | |
| 6.6634% | |
| -5.0522% | |
| -37.404% | |
| -31.9627% | |
| 47.3675% | |
| 99.6973% | |
| 97.7363% | |
| 0% |